Eric Cramer is chairman of Berger Montague PC and co-chair of the firm’s antitrust department. He has a national practice in the field of complex litigation, primarily in the area of antitrust class actions. He is currently co-lead counsel in multiple significant antitrust class actions across the country in a variety of industries and is responsible for winning numerous significant settlements for his clients totaling well over $3 billion. Most recently, he has focused on representing workers claiming that anticompetitive practices have suppressed their pay, including cases on behalf of mixed-martial-arts fighters, luxury retail workers, and chicken growers.
In 2020, Law360 named Mr. Cramer a Titan of the Plaintiffs Bar, and Who’s Who Legal identified him as a Global Elite Thought Leader, stating that he “comes recommended by peers as a top name for antitrust class action proceedings.” In 2019, The National Law Journal awarded Mr. Cramer the Keith Givens Visionary Award, which was developed to honor an outstanding trial lawyer who has moved the industry forward through his or her work within the legal industry ecosystem, demonstrating excellence in all aspects of work from client advocacy to peer education and mentoring. In 2018, he was named Philadelphia antitrust “Lawyer of the Year” by Best Lawyers, and in 2017, he won the American Antitrust Institute’s Antitrust Enforcement Award for Outstanding Antitrust Litigation Achievement in Private Law Practice for his work in Castro v. Sanofi Pasteur Inc., No. 11-cv-07178 (D.N.J.). In that case, Mr. Cramer represented a national class of physicians challenging Sanofi Pasteur with anticompetitive conduct in the market for meningitis vaccines, resulting in a settlement of more than $60 million for the class. He has also been identified as a top tier antitrust lawyer by Chambers & Partners in Pennsylvania and nationally. In 2020, Chambers & Partners observed that Mr. Cramer is “a fantastic lawyer…He has real trial experience and is very capable and super smart.” He has been highlighted annually since 2011 by The Legal 500 as one of the country’s top lawyers in the field of complex antitrust litigation and repeatedly deemed one of the “Best Lawyers in America,” including for 2021. In 2014 and 2018, Mr. Cramer was selected by Philadelphia Magazine as one of the top 100 lawyers in Philadelphia.
Mr. Cramer is also a frequent speaker at antitrust and litigation related conferences and a leader of multiple non-profit advocacy groups. He is president of the Board of Directors of Public Justice, a national public interest advocacy group and law firm; a senior fellow of the American Antitrust Institute; a past President of COSAL (Committee to Support the Antitrust Laws), a leading industry group; and a member of the Advisory Board of the Institute of Consumer Antitrust Studies of the Loyola University Chicago School of Law. He was the only Plaintiffs’ lawyer selected to serve on the American Bar Association’s Antitrust Section Transition Report Task Force delivered to the incoming Obama Administration in 2012.
He has written widely in the fields of class certification and antitrust law. Among other writings, Mr. Cramer has co-authored Antitrust, Class Certification, and the Politics of Procedure, 17 George Mason Law Review 4 (2010), which was cited by both the First Circuit in In re Nexium Antitrust Litig., 777 F.3d 9, 27 (1st Cir. 2015), quoting Davis & Cramer, 17 Geo. Mason L. Rev. 969, 984-85 (2010), and the Third Circuit in Behrend v. Comcast Corp., 655 F.3d 182, 200, n.10 (3d Cir. 2011), rev’d on other grounds, 133 S. Ct. 1426 (2013). He has also co-written a number of other pieces, including: Of Vulnerable Monopolists?: Questionable Innovation in the Standard for Class Certification in Antitrust Cases, 41 Rutgers Law Journal 355 (2009-2010); A Questionable New Standard for Class Certification in Antitrust Cases, published in the ABA’s Antitrust Magazine, Vol. 26, No. 1 (Fall 2011); a Chapter of American Antitrust Institute’s Private International Enforcement Handbook (2010), entitled “Who May Pursue a Private Claim?”; and a chapter of the American Bar Association’s Pharmaceutical Industry Handbook (July 2009), entitled “Assessing Market Power in the Prescription Pharmaceutical Industry.”
Mr. Cramer is a summa cum laude graduate of Princeton University (1989), where he earned membership in Phi Beta Kappa. He graduated cum laude from Harvard Law School with a J.D. in 1993.
